ClinicalTrials.gg
TerminatedNCT01777854Updated Oct 24, 2018Results posted

Anti-reflux Control to Decrease Post Tonsillectomy Pain

A Phase 4 interventional study of Omeprazole in Laryngopharyngeal Reflux and Throat Pain, sponsored by Ascension Health. Terminated at 1 site in United States. Open to participants aged 7 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-24.

Sponsored by Ascension Health · Phase 4, Interventional, and Prevention

Why this study was terminated
Lack of patient interest in the study.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
7 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 26 studies in Laryngopharyngeal Reflux with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Laryngopharyngeal Reflux · United States.

Enrollment
17th of 21
6 · median 43
Started
2013
with 2 others
Phase 4
7 of 26
1 open now
Registered
14th of 26
by date
Lead sponsor
1 of 26
Ascension Health

Among the 26 studies in Laryngopharyngeal Reflux with a site in United States, this one is the 17th largest by enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2013, is one of 7 in phase 4, and was the 14th registered.

Laryngopharyngeal Reflux

56 studies on the registry are indexed under Laryngopharyngeal Reflux; 8 are open to participants now.

Browse Laryngopharyngeal Reflux studies →

Open to participants now

3 of the 26 studies in Laryngopharyngeal Reflux with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 5 Laryngopharyngeal Reflux studies recruiting now, 1 sets no upper age limit and 2 stop at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 7 Years to 17 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Laryngopharyngeal Reflux with a site in United States, or all of them as a file.
02

Study summary

The study aims to determine if treating pediatric patients (age 7-17) for four weeks with omeprazole prior to tonsillectomy will decrease post tonsillectomy pain. The hypothesis is that many patients have silent laryngopharyngeal reflux and by reducing the acid entrance into the oropharynx, patients will have less post tonsillectomy pain due to decreased acid irritation of the surgical wound (tonsil fossas).

The study will be a prospective double blind randomized study. Participants will be invited to participate in the study by giving the study information at the preoperative assessment, when the decision is made to have a tonsillectomy performed. If the patient agrees to participate in the study, a written consent and child assent will be obtained and the patient will be randomly assigned to a treatment versus control group based on the randomly assigned participant number.

The treatment group will then be given a four week course of omeprazole to be taken for the four weeks prior to tonsillectomy. The patient will be given a post tonsillectomy assessment form. The form looks at postoperative pain (using a visual analog scale 1-10) as well as oral intake at postoperative day 0,1,3,5,7,10, and 14. The form will be turned in at the postoperative visit or mailed in.

The pain level and oral intake between the two groups to will be compared to determine if antireflux control helps decrease the postoperative pain after tonsillectomy.

Read the detailed description

The study aims to determine if treating pediatric patients (age 7-18) for four weeks with omeprazole prior to tonsillectomy will decrease post tonsillectomy pain. The hypothesis is that many patients have silent laryngopharyngeal reflux and by reducing the acid entrance into the oropharynx, patients will have less post tonsillectomy pain due to decreased acid irritation of the surgical wound (tonsil fossas).

The study will be a prospective double blind randomized study. Participants will be invited to participate in the study by giving the study information at the preoperative assessment, when the decision is made to have a tonsillectomy performed. If the patient agrees to participate in the study, a written consent and child assent will be obtained and the patient will be randomly assigned to a treatment versus control group based on the randomly assigned participant number.

The treatment group will then be given a four week course of omeprazole or placebo to be taken for the four weeks prior to tonsillectomy. The investigators will be blinded to the intervention. The medication will be kept in a locked drawer at the ENT Associates office. The patient will take the medication 20 mg orally once a day for 28 days prior to the procedure with day 28 being the day before the tonsillectomy. The patient will be provided with a calender that is marked with the start date of the medication. The patient is to document any missed doses on the calender. On the day of surgery, the patient will return the remainder of the medication in an opaque bag along with the calender and this will be given back to the research pharmacist to account for the medication.

The patient will be given a post tonsillectomy assessment form. The form looks at postoperative pain (using a visual analog scale 1-10) as well as oral intake at postoperative day 0,1,3,5,7,10, and 14. The form will be turned in at the postoperative visit (2 weeks after the surgery) or mailed in.

The pain level and oral intake between the two groups to will be compared to determine if antireflux control helps decrease the postoperative pain after tonsillectomy.

Other variables collected will be patient age, gender, method of surgery, pain medication prescribed, and indication for procedure. The data will be stored in a password protected computer files and the patient will only be identified by study number.

03

Conditions studied

  • Laryngopharyngeal Reflux
  • Throat Pain
04

Who can participate

Ages eligible
7 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 7-17 years old
  • Weight >20 kg
  • Scheduled to undergo a tonsillectomy (with or without adenoidectomy) in greater than four weeks.
  • Health conditions (any of the following): Hypertrophic tonsils and adenoids, sleep disordered breathing, obstructive sleep apnea, chronic or recurrent tonsillitis, halitosis, dysphagia
  • Must be able to swallow pills or tolerate taking the medication sprinkled on applesauce or other soft food.

Exclusion criteria

Exclusion Criteria:

  • Age \<7
  • Weight \<20kg
  • Patients declared by the parent not able to communicate pain level.
  • Patients whose tonsillectomy is scheduled \<4 weeks from the preoperative assessment (The patient would not have time to complete the preoperative treatment) (An exception to this exclusion criteria will be for the control group)
  • Patients with a mental illness. This will be determined by the patient's physician or the physician overseeing the care of the patient.
  • Unable to swallow pills or tolerate sprinkling the medication on soft food.
  • Pregnant patients
  • Any patients already taking Proton Pump Inhibitor
05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
6 participants (actual)

Study arms

  • Active comparator
    Omeprazole

    Yes. Omeprazole (generic) will be used. Children \>20 kg will be given 20 mg PO daily for 4 weeks prior to tonsillectomy. This is the normal standard pediatric dosing for reflux. Omeprazole is authorized to treat reflux in children. The study focuses on laryngopharyngeal reflux that possibly contributes to post tonsillectomy pain.

    Drug: Omeprazole

  • Placebo comparator
    Sugar pill

    The placebo does not look like the omeprazole, however this will not be an issue because none of the subjects will have knowledge of how the medications look.

    Drug: Omeprazole

Interventions

  • The principal investigator will be contacted and will work with the research pharmacist to obtain the omeprazole (20 mg PO daily for patients \>20kg) and placebo. The placebo does not look like the omeprazole, however this will not be an issue because none of the subjects will have knowledge of how the medications look. The medication will be locked in the designated medication cabinet at each office. It will be prepackaged for a 28 day course. The patient will start the treatment 4 weeks prior to tonsillectomy and stop the day before surgery. The medication will be given to the patient once the consent and assent are signed. This will avoid an unnecessary office visit to improve patient compliance.

    Also known as: Prilosec, Prilosec OTC

06

What researchers measure

Primary outcomes

  1. Pain After Tonsillectomy

    A questionnaire will be given to patients. Patients are asked to describe their pain and oral intake on post op days 0,1,3,5,7,10 and 14. This should take less than one minute per assessment day. At the end of the survey, they are asked to comment on any postoperative problems such as hemorrhage or dehydration. This should take less than 5 minutes. Parents will be asked to assist the child in completing the survey. They will be asked to turn in the form on the postoperative follow up visit (14-21 days after surgery) or mail it in to the principal investigator if the surgeon does not have a postoperative follow up visit. For these patients, an addressed and stamped envelope will be provided.

    Time frame: 2 weeks

07

Results

Posted Sep 25, 2018

Participant flow

Participant flow — Overall Study
MilestoneOmeprazoleSugar Pill
Started33
Completed00
Not completed33
Withdrew: Physician decision33

Outcome measures

PrimaryPain After Tonsillectomy

A questionnaire will be given to patients. Patients are asked to describe their pain and oral intake on post op days 0,1,3,5,7,10 and 14. This should take less than one minute per assessment day. At the end of the survey, they are asked to comment on any postoperative problems such as hemorrhage or dehydration. This should take less than 5 minutes. Parents will be asked to assist the child in completing the survey. They will be asked to turn in the form on the postoperative follow up visit (14-21 days after surgery) or mail it in to the principal investigator if the surgeon does not have a postoperative follow up visit. For these patients, an addressed and stamped envelope will be provided.

Time frame:
2 weeks

No measurements were reported for this outcome.

Adverse events

Collected over The data was not collected.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pre Treatment———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Pre Treatment
<=18 years6
Between 18 and 65 years0
>=65 years0
Age, Continuous
Age, Continuous(years)Pre Treatment
Mean14 (7 to 17)
Sex: Female, Male
Sex: Female, Male(Participants)Pre Treatment
Female3
Male3
Region of Enrollment
Region of Enrollment(participants)Pre Treatment
United States6
08

Study locations

1 site
  • Genesys Regional Medical Center
    Grand Blanc, Michigan 48439, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2013, a primary completion of Jul 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.

Results were first posted in Sep 2018, 3 years 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 25, 2013
First posted
Jan 29, 2013
Start
Jan 2013
Primary completionActual
Jul 2015
CompletionActual
Jul 2015
Results first posted
Sep 25, 2018
Last update
Oct 24, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 24, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01777854
Lead sponsor
Ascension Health
Responsible party
Carissa Wentland DO (DO/Otolaryngology Resident, Ascension Health) — Principal investigator
First posted
Jan 29, 2013
Start date
Jan 2013
Primary completion
Jul 2015
Completion
Jul 2015
Results posted
Sep 25, 2018
Last update
Oct 24, 2018

Study contacts

Carissa J Wentland, DO
principal investigator · Ascension Health
Kimberly Barber, PhD
study director · Ascension Health
Candy Rainwater
study director · Ascension Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Omeprazole

Start the discussion